Squadra avocats assisted Amphastar France Pharmaceuticals
Amphastar Pharmaceuticals is a biopharmaceutical company that is engaged in the development, manufacture and marketing of generic and proprietary injectable, intranasal and inhalation products.
Amphastar France Pharmaceuticals was advised by Squadra Avocats, whose Corporate-M&A team was led by François Lan, partner, with Arnaud Bourdelat, associate.